SAFE Study: Safety of aPCC Following Emicizumab Prophylaxis
Clinical trial NCT04563520 · RECRUITING
Trial details
- NCT number
- NCT04563520
- Sponsor
- Emory University
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-01
- Primary completion
- 2027-03-01
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.